Last reviewed · How we verify
Phase I/II Trial to Evaluate the Safety and Immunogenicity of AIDSVAX B/B and B/E Vaccines in the United States
The purpose of this study is to see if it is safe and effective to give AIDSVAX B/B or AIDSVAX B/E, two potential HIV vaccines, to HIV-negative volunteers.
Details
| Lead sponsor | VaxGen |
|---|---|
| Phase | Phase 1 |
| Status | COMPLETED |
| Enrolment | 120 |
Conditions
- HIV Infections
Interventions
- MN rgp120/HIV-1 and GNE8 rgp120/HIV-1
- MN rgp120/HIV-1 and A244 rgp120/HIV-1
- Aluminum hydroxide
Countries
United States